Author

Daniel L. Marks

ORCID 0000-0003-2675-7047Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

Russell Potterfield· 2 shared Aaron J. GrossbergiD· 1 shared Anna Chiara ImpastatoiD· 1 shared Barry A. BadeauiD· 1 shared Benjamin H. RajewskiiD· 1 shared Bradley Studnitzer· 1 shared Claudia R. PrindleiD· 1 shared E. Zhang· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Russell Potterfield

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintNov 25, 2025

Dual Activation of MC3R and MC4R Drives Weight Loss and Reduces Food Intake in Obese Primates

Jillian L. Seiler, Anna Chiara Impastato, E. Zhang…·Daniel L. Marks

This study shows that activating both MC3R and MC4R in obese primates leads to weight loss and reduced food intake, with a new dual agonist peptide showing efficacy and safety.

2 citations

non-human primateexperimental assay

𝕏 PostBluesky

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedNov 7, 2024

Melanocortin-4 receptor antagonist TCMCB07 alleviates chemotherapy-induced anorexia and weight loss

Xinxia Zhu, Russell Potterfield, Kenneth A. Gruber…·Daniel L. Marks

This study shows that TCMCB07, a melanocortin-4 receptor antagonist, reduces chemotherapy-induced anorexia and weight loss in rat models.

10 citations

ratexperimental assay

𝕏 PostBluesky